Selectis Health, Inc. (GBCS) Stock

About Selectis Health, Inc.

Selectis Health, Inc., formerly known as Global Healthcare REIT, Inc., was originally established with the intention of operating as a real estate investment trust (REIT) focused on investments in healthcare-related real estate and assets. Over time, the company's strategic emphasis has shifted; rather than primarily leasing nursing home properties to independent operators, it now increasingly owns and directly manages its real estate holdings. Consequently, the organization no longer plans to pursue or maintain its REIT qualification. It is also actively exploring a change of its corporate name and other foundational charter amendments to more accurately represent its revised business model. Historically, before adopting the name Global Healthcare REIT, Inc. on September 30, 2013, the company operated as Global Casinos, Inc., managing two gaming facilities. On that pivotal date, Global Casinos, Inc. divested these gaming operations through a split-off and sale. This move coincided with the acquisition of West Paces Ferry Healthcare REIT, Inc. (WPF) in a transaction structured as a reverse acquisition, where WPF was considered the accounting acquirer. Presently, the company's core activities involve the acquisition, development, leasing, management, and eventual disposition of real estate assets within the healthcare industry. It also extends financing solutions to healthcare providers. As of September 30, 2020, the company's portfolio comprised twelve healthcare properties. These assets are either leased or managed by independent third-party operators under triple-net lease agreements, or they are directly managed and operated by the company itself. The organization makes a strategic decision to operate facilities internally when it determines such an approach to be most beneficial and efficient.

Selectis Health, Inc. is headquartered in US.

Selectis Health, Inc. (GBCS) stock trades at $5.41 with a market capitalization of $16.59M. The stock is valued at a price-to-earnings (P/E) ratio of 2.69, price-to-book of 64.23, price-to-sales of 0.43. Over the past 52 weeks the stock has ranged between $1.50 and $5.60, and currently trades 3.4% below its 52-week high.

On profitability, Selectis Health, Inc. generates a return on equity (ROE) of -136.86%, return on capital employed of -9.20%, an operating margin of -6.29%, a net profit margin of 16.11%.

Official website: www.selectis.com